Dermatologic

RSS

MedImmune seeks FDA approval for psoriasis trials with MEDI-507

Nov. 28, 1997

Clinical efficacy of naltrexone demonstrated in patients with cholestatic pruritus

Nov. 27, 1997

New histamine antagonists described for dermatological indications

Nov. 21, 1997

Phase II begins for psoriasis vaccine

Nov. 20, 1997

Rogaine Extra Strength approved by FDA as OTC

Nov. 19, 1997

Cellegy to acquire nitroglycerin-based product for anorectal conditions

Nov. 6, 1997

KGF fragments from Chiron display wound-healing activity

Nov. 5, 1997

Lifecore reaches patient enrollment milestone in Intergel study

Oct. 30, 1997

Differin is equieffective but better tolerated than Retin A in patients with acne

Oct. 29, 1997

Apligraf comparable to autograft for donor site wounds

Oct. 29, 1997